Literature DB >> 22801218

Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.

Qing Wang1, Yan Zhang, Hsin-Sheng Yang.   

Abstract

Programmed cell death 4 (Pdcd4) is a novel tumor suppressor, whose expression is frequently down-regulated in several types of cancers. In the present study, we demonstrated that Pdcd4 knockdown up-regulates MAP kinase kinase kinase kinase 1 (MAP4K1) expression and increases phosphorylation of c-Jun. Over-expression of c-Myc in HEK293 cells increases the levels of MAP4K1, MAP4K1 promoter activity, and phospho-c-Jun. Mutation analysis showed that the c-Myc binding site at -536bp (relative to the initiation ATG) of map4k1 promoter responds to c-Myc regulation. In addition, chromatin immunoprecipitation demonstrated that c-Myc directly binds to map4k1 promoter at this site. Down-regulation of c-Myc reverses MAP4K1 expression and AP-1 activation in Pdcd4 knockdown cells. Moreover, over-expression of dominant negative Tcf4 decreases expression of c-Myc and MAP4K1, JNK activation, and AP-1 dependent transcription. Thus, activation of β-catenin/Tcf dependent transcription in Pdcd4 knockdown cells up-regulates MAP4K1 expression and AP-1 activity via c-Myc. The study presented here further reveals in detail the mechanism of how Pdcd4 inhibits tumor cell invasion and provides a functional connection between β-catenin/Tcf and AP-1 dependent transcription.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801218      PMCID: PMC3725281          DOI: 10.1016/j.bbamcr.2012.07.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  41 in total

1.  Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms.

Authors:  Mayumi Nakashima; Hiroshi Hamajima; Jinghe Xia; Shinji Iwane; Yasunori Kwaguchi; Yuichiro Eguchi; Toshihiko Mizuta; Kazuma Fujimoto; Iwata Ozaki; Sachiko Matsuhashi
Journal:  Biochim Biophys Acta       Date:  2010-05-12

2.  Leukocyte-specific adaptor protein Grap2 interacts with hematopoietic progenitor kinase 1 (HPK1) to activate JNK signaling pathway in T lymphocytes.

Authors:  W Ma; C Xia; P Ling; M Qiu; Y Luo; T H Tan; M Liu
Journal:  Oncogene       Date:  2001-03-29       Impact factor: 9.867

3.  Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death.

Authors:  K Shibahara; M Asano; Y Ishida; T Aoki; T Koike; T Honjo
Journal:  Gene       Date:  1995-12-12       Impact factor: 3.688

4.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Authors:  Aaron P Jansen; Corinne E Camalier; Nancy H Colburn
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

5.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

6.  Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.

Authors:  Tobias Schmid; Aaron P Jansen; Alyson R Baker; Glenn Hegamyer; John P Hagan; Nancy H Colburn
Journal:  Cancer Res       Date:  2008-02-22       Impact factor: 12.701

7.  A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun.

Authors:  Simon Morton; Roger J Davis; Ann McLaren; Philip Cohen
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

8.  Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.

Authors:  Olubunmi Afonja; Dominique Juste; Sharmistha Das; Sachiko Matsuhashi; Herbert H Samuels
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

9.  The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.

Authors:  Cristina Corzo; Josep M Corominas; Ignacio Tusquets; Marta Salido; Meritxell Bellet; Xavier Fabregat; Sergio Serrano; Francesc Solé
Journal:  Cancer Genet Cytogenet       Date:  2006-03

10.  Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer.

Authors:  Na Wei; Stephanie S Liu; Karen K L Chan; Hextan Y S Ngan
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

View more
  15 in total

1.  Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation.

Authors:  Amitava Das; Kasturi Ganesh; Savita Khanna; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

Review 2.  The role of Pdcd4 in tumour suppression and protein translation.

Authors:  Qing Wang; Hsin-Sheng Yang
Journal:  Biol Cell       Date:  2018-05-28       Impact factor: 4.458

3.  Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.

Authors:  Ramesh C Kovi; Sachin Bhusari; Deepak Mav; Ruchir R Shah; Thai Vu Ton; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2019-07-05       Impact factor: 5.153

4.  Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.

Authors:  Y Yang; H Meng; Q Peng; X Yang; R Gan; L Zhao; Z Chen; J Lu; Q H Meng
Journal:  Cancer Gene Ther       Date:  2014-12-05       Impact factor: 5.987

5.  Inhibition of p70S6K1 Activation by Pdcd4 Overcomes the Resistance to an IGF-1R/IR Inhibitor in Colon Carcinoma Cells.

Authors:  Yan Zhang; Qing Wang; Li Chen; Hsin-Sheng Yang
Journal:  Mol Cancer Ther       Date:  2015-01-08       Impact factor: 6.261

6.  Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice.

Authors:  Qing Wang; Jiang Zhu; Yong Zhang; Zhenxiao Sun; Xiaoling Guo; Xin Wang; Eun Lee; Vasudevan Bakthavatchalu; Qifeng Yang; Hsin-Sheng Yang
Journal:  Eur J Cancer       Date:  2013-01-10       Impact factor: 9.162

7.  Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA.

Authors:  Fang Bai; Kangdong Liu; Huiliang Li; Jiawei Wang; Junsheng Zhu; Pei Hao; Lili Zhu; Shoude Zhang; Lei Shan; Weiya Ma; Ann M Bode; Weidong Zhang; Honglin Li; Zigang Dong
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

8.  Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.

Authors:  Q Wang; J Zhu; Y-W Wang; Y Dai; Y-L Wang; C Wang; J Liu; A Baker; N H Colburn; H-S Yang
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

Review 9.  Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions.

Authors:  Sachiko Matsuhashi; M Manirujjaman; Hiroshi Hamajima; Iwata Ozaki
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

10.  Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation.

Authors:  Lu Shen; Min Ling; Yuan Li; Yuan Xu; Yun Zhou; Jing Ye; Ying Pang; Yue Zhao; Rongrong Jiang; Jianping Zhang; Qizhan Liu
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.